MiniMed Group, Inc. (MMED)
18.76
+0.77
(+4.28%)
USD |
NASDAQ |
Nov 16, 11:32
MiniMed Group Enterprise Value : 4.911B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.911B |
| November 12, 2026 | 4.879B |
| November 11, 2026 | 4.984B |
| November 10, 2026 | 4.734B |
| November 09, 2026 | 4.880B |
| November 06, 2026 | 4.551B |
| November 05, 2026 | 4.957B |
| November 04, 2026 | 5.276B |
| November 03, 2026 | 5.153B |
| November 02, 2026 | 5.167B |
| October 30, 2026 | 4.992B |
| October 29, 2026 | 5.265B |
| October 28, 2026 | 5.254B |
| October 27, 2026 | 5.175B |
| October 26, 2026 | 5.099B |
| October 23, 2026 | 5.009B |
| October 22, 2026 | 4.995B |
| October 21, 2026 | 4.857B |
| October 20, 2026 | 4.770B |
| October 19, 2026 | 4.855B |
| October 16, 2026 | 4.770B |
| October 15, 2026 | 4.914B |
| October 14, 2026 | 4.579B |
| October 13, 2026 | 5.026B |
| October 12, 2026 | 5.139B |
| Date | Value |
|---|---|
| October 09, 2026 | 5.395B |
| October 08, 2026 | 5.420B |
| October 07, 2026 | 5.226B |
| October 06, 2026 | 5.375B |
| October 05, 2026 | 5.521B |
| October 02, 2026 | 5.392B |
| October 01, 2026 | 5.364B |
| September 30, 2026 | 5.327B |
| September 29, 2026 | 5.487B |
| September 28, 2026 | 5.614B |
| September 25, 2026 | 5.470B |
| September 24, 2026 | 5.600B |
| September 23, 2026 | 5.628B |
| September 22, 2026 | 5.814B |
| September 21, 2026 | 5.791B |
| September 18, 2026 | 5.979B |
| September 17, 2026 | 6.047B |
| September 16, 2026 | 6.151B |
| September 15, 2026 | 6.041B |
| September 14, 2026 | 6.030B |
| September 11, 2026 | 6.179B |
| September 10, 2026 | 6.162B |
| September 09, 2026 | 6.252B |
| September 08, 2026 | 6.410B |
| September 04, 2026 | 6.400B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 215.41B |
| Baxter International, Inc. | 19.36B |
| Becton, Dickinson & Co. | 74.72B |
| Boston Scientific Corp. | 75.80B |
| Insulet Corp. | 10.95B |
Enterprise Value Related Metrics
| Revenue (Quarterly) | 843.00M |
| Total Expenses (Quarterly) | 843.00M |
| Gross Profit Margin (Quarterly) | 55.04% |
| Earnings Yield | -6.09% |
| Operating Earnings Yield | 7.57% |
| Normalized Earnings Yield | -0.6855 |